Growth Metrics

Insulet (PODD) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Insulet (PODD) over the last 17 years, with Q3 2025 value amounting to $392.4 million.

  • Insulet's Operating Expenses rose 3577.85% to $392.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 2757.69%. This contributed to the annual value of $1.1 billion for FY2024, which is 2094.9% up from last year.
  • Per Insulet's latest filing, its Operating Expenses stood at $392.4 million for Q3 2025, which was up 3577.85% from $331.1 million recorded in Q2 2025.
  • Insulet's Operating Expenses' 5-year high stood at $392.4 million during Q3 2025, with a 5-year trough of $37.5 million in Q3 2021.
  • In the last 5 years, Insulet's Operating Expenses had a median value of $233.8 million in 2023 and averaged $213.1 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first tumbled by 335.05% in 2021, then surged by 44114.71% in 2022.
  • Over the past 5 years, Insulet's Operating Expenses (Quarter) stood at $41.8 million in 2021, then surged by 363.64% to $193.8 million in 2022, then skyrocketed by 31.48% to $254.8 million in 2023, then rose by 26.18% to $321.5 million in 2024, then rose by 22.05% to $392.4 million in 2025.
  • Its Operating Expenses was $392.4 million in Q3 2025, compared to $331.1 million in Q2 2025 and $320.2 million in Q1 2025.